<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696172</url>
  </required_header>
  <id_info>
    <org_study_id>V1.0</org_study_id>
    <nct_id>NCT04696172</nct_id>
  </id_info>
  <brief_title>Explore Potential Plasma Biomarkers of Acute Respiratory Distress Syndrome (ARDS) Using Proteomics Analysis in Patients Undergoing Cardiopulmonary Bypass</brief_title>
  <acronym>PBOARDS</acronym>
  <official_title>Explore Potential Plasma Biomarkers of Acute Respiratory Distress Syndrome (ARDS) Using Proteomics Analysis in Patients Undergoing Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wuhan Asia Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to establish a prospective cohort of patients undergoing&#xD;
      cardiopulmonary bypass (CPB) in cardiac surgery from April 2021 to September 2022, in Wuhan.&#xD;
      The ARDS events, ventilation time, time of extubation, oxygenation index for 3 days after&#xD;
      operation, length of ICU stay and postoperative death events were observed. Plasma samples&#xD;
      were collected before CPB, and several time points after CPB. Dynamic differential proteins&#xD;
      of ARDS after CPB were screened by DIA (Data independent acquisition) proteomics.&#xD;
      Quantitative protein marker concentration was used to predict the occurrence of ARDS after&#xD;
      operation, the model discrimination and calibration was assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Week</target_duration>
  <primary_outcome>
    <measure>Number of participants with postoperative ARDS events as assessed by Berlin Definition.</measure>
    <time_frame>3 days after operation</time_frame>
    <description>The Berlin Definition of Acute Respiratory Distress Syndrome:&#xD;
Timing: Within 1 week of a known clinical insult or new or worsening respiratory symptoms;&#xD;
Chest imaging: Bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules;&#xD;
Origin of edema: Respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present;&#xD;
Oxygenation:&#xD;
Mild 200 mm Hg &lt;PaO2/FIO2≤ 300 mm Hg with PEEP or CPAP ≥5 cm H2O; Moderate 100 mm Hg &lt;PaO2/FIO2≤ 200 mm Hg with PEEP ≥5 cm H2O Severe PaO2/FIO2≤ 100 mm Hg with PEEP ≥5 cm H2O</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients undergoing cardiopulmonary bypass (CPB) with postoperative ARDS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients undergoing cardiopulmonary bypass (CPB) without postoperative ARDS</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiopulmonary bypass (CPB) in cardiac surgery from March 2021 to&#xD;
        September 2022, in Wuhan Union hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Selective operation;&#xD;
&#xD;
          -  Cardiac surgery with cardiopulmonary bypass;&#xD;
&#xD;
          -  Adult patients over 18 years old;&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  emergency surgery;&#xD;
&#xD;
          -  previous cardiac surgery;&#xD;
&#xD;
          -  previous liver cirrhosis;&#xD;
&#xD;
          -  preoperative pulmonary function problems: pulmonary insufficiency such as hypoxemia,&#xD;
             pulmonary inflammation, respiratory failure, etc.;&#xD;
&#xD;
          -  preoperative ventilator or extracorporeal membrane oxygenation support;&#xD;
&#xD;
          -  preoperative pulmonary function problems;&#xD;
&#xD;
          -  ARDS occurred during the operation;&#xD;
&#xD;
          -  death occurred during the operation;&#xD;
&#xD;
          -  extracorporeal membrane oxygenation support was needed after the operation or CPB was&#xD;
             performed again within 3 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yu Wang, PhD.</last_name>
    <phone>+86 15972918891</phone>
    <email>wangdayuanesthe@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Union Hospital, Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Wang, Dr.</last_name>
      <phone>+86 15972918891</phone>
      <email>wangdayuanesthe@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wuhan Asia Heart Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Weiqin Huang, Dr.</last_name>
      <phone>+86 13986115788</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 28, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wuhan Union Hospital, China</investigator_affiliation>
    <investigator_full_name>Shanglong Yao</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Acute Respiratory Distress Syndrome</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Proteomics</keyword>
  <keyword>Cardiopulmonary Bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

